Compass Therapeutics Financial Overview
Compass Therapeutics's market cap is currently $882.20M. The company's EPS TTM is $-0.08; its P/E ratio is -11.01; Compass Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
